Table 1.

Patient demographics, performed operations, tumor diameters, and histopathological diagnoses

operation	ID	Age range	Resection of MHV	Tumor entity	Intrahepatic tumor diameter(s) (CT)	Histopathological diagnosis of resected non-neoplastic liver parenchyma
left hemi-hepatectomy	1	55–59 yrs.	no	CC	1.8 cm	portal fibrosis with formation of septa
	2	80–84 yrs.	no	CC	1.4 cm	extensive parenchymal necrosis
	3	65–69 yrs.	yes	CC	3.2 cm	n.e.
	4	60–64 yrs.	yes	CC	11.0 cm	n.e.
	5	65–69 yrs.	yes	CC	5.0 cm	portal fibrosis with formation of septa
	6	75–79 yrs.	no	CC	1.8 cm	portal fibrosis with formation of septa
right hemi-hepatectomy	7	60–64 yrs.	no	3 metastases (CRC)	2.2 cm to 5.7 cm	n.e.
	8	70–74 yrs.	no	CC	6.4 cm	portal fibrosis with formation of septa
	9	50–54 yrs.	no	6 metastases (CRC)	1.2 cm to 3.3 cm	n.e.
	10	65–69 yrs.	no	5 metastasis (MM)	1.2 cm to 6.0 cm	n.e.
	11	60–64 yrs.	yes	CC	2.2 cm	n.e.
	12	75–79 yrs.	no	1 metastasis (CRC)	5.9 cm	n.e.
	13	45–49 yrs.	no	9 metastases (GCT)	1.4 cm to 3.2 cm	n.e.
	14	65–69 yrs.	no	HCC	7.7 cm	n.e.
	15	60–64 yrs.	no	CC (2 foci)	1.4 cm to 10.1 cm	portal fibrosis with formation of septa
	16	70–74 yrs.	no	CC	1.7 cm	n.e.
	17	50–54 yrs.	no	6 metastases (TC)	1.3 cm to 2.9 cm	hepatic steatosis
extended right hemi-hepatectomy	18	30–34 yrs.	yes	CC	2.9 cm	n.e.
	19	60–64 yrs.	yes	3 metastases (TC)	1.8 cm to 13.8 cm	extensive parenchymal necrosis
	20	60–64 yrs.	yes	CC	11.8 cm	n.e.
	21	70–74 yrs.	yes	3 metastases (CRC)	5.1 cm to 9.5 cm	n.e.
	22	55–59 yrs.	yes	5 metastases (CRC)	3.8 cm to 6.7 cm	n.e.
	23	65–69 yrs.	yes	CC	1.0 cm	extensive parenchymal necrosis
	24	55–59 yrs.	yes	CC	1.5 cm	portal fibrosis with formation of septa

f female, m male, yrs. years, MHV middle hepatic vein CC cholangiocarcinoma, GCT granulosa cell tumor, HCC hepatocellular carcinoma, MM malignant melanoma, TC thyroid carcinoma, n.e. no evidence of steatosis, portal fibrosis with formation of septa or parenchymal necrosis